6533b861fe1ef96bd12c45d0

RESEARCH PRODUCT

Transplantation in follicular lymphoma: not "yes or no" but "whom and when".

Ralf G. MeyerGeorg Hess

subject

Oncologymedicine.medical_specialtyPathologybusiness.industryPatient SelectionFollicular lymphomaHematopoietic Stem Cell TransplantationHematopoietic stem cellEditorials and PerspectivesHematologymedicine.diseaseTransplantation AutologousLymphomaIndolent lymphomaTransplantationmedicine.anatomical_structureimmune system diseaseshemic and lymphatic diseasesInternal medicinemedicineHumansbusinessLymphoma Follicular

description

After years of debate, the question as to what is the optimal use of transplantation strategies in indolent lymphoma remains controversial. In the July issue of Haematologica, a study was published by the EBMT Lymphoma Working Party that aims to define indications for hematopoietic stem cell

10.3324/haematol.2013.091538https://pubmed.ncbi.nlm.nih.gov/24006405